Delivery Order SPE2DB20D2014-SPE2DB25FA45P

Award Date 11/27/24
Potential Completion Date 11/29/24
Potential Value $1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,098.70 Firm Fixed Price delivery order is for the supply of 4,565,744,291 tablets of Methylphenidate ER 36 mg. The contract has an ultimate completion date of September 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,498.80 firm fixed-price delivery order is for the supply of 4,567,972,776 units of the medication methylergonovine 0.2 mg tablet in 20-count units. The contract has an ultimate completion date of April 21, 2025 and was awarded on April 19, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,237.38 contract is for the delivery of 4,568,119,737 milliliters of the medication Medroxyprogesterone 150 mg/ml. The award has an ultimate completion date of May 5, 2025. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,410.20, is for the delivery of 4568112775 methylergonovine 0.2 mg tablets. The contract has a period of performance through May 5, 2025 and is a firm fixed-price contract. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,332.20 firm fixed-price contract is for the delivery of 4,568,260,604 milliliters of the drug medroxyprogesterone 150 mg/mL. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,347.93 firm fixed-price delivery order is for the supply of 4565150115 - Methylergonovine 0.2 mg Tablet 12s, with a completion date of July 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp is for the delivery of 4,566,122,144 units of Methylphenidate ER 36 mg tablets in 100-count bottles. The firm-fixed-price delivery order, valued at $1,183.58, has an ultimate completion date of October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The current Delivery Order, valued at $4,402.80, is for the supply of 4559592833 - Junel FE 1.5 mg-30 mcg tablets, with a completion date of January 13, 2023. This IDC serves as a primary vehicle for Amerisourcebergen to provide a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,594.32 Firm Fixed Price Delivery Order contract is for the supply of MESALAMINE DR 1.2 GM TABLET 120S, with a completion date of April 14, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
The Defense Logistics Agency awarded a $889.88 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 100 tablets of 40mg Megestrol, a medication used to treat certain cancers and AIDS/HIV wasting syndrome. The order was placed under an existing prime vendor contract vehicle and will be fulfilled from Amerisourcebergen's facility located in Conshohocken, Pennsylvania by July 17, 2023 to support DLA programs. No subcontractors or set aside designations were...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FA45P
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,016.50, is for the delivery of 4,566,566,355 units of the medication Megestrol 40 mg Tablet. The contract is a Firm Fixed Price arrangement running from November 27, 2024 to November 29, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

The contract award does not indicate any set-aside designation, suggesting open competition. The primary contracting agency is the DLA, with the delivery order supporting military treatment facilities, veterans' healthcare programs, and other federal medical institutions.

Generated 2/26/25, 9:45 AM